Your browser doesn't support javascript.
loading
Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitor.
Zhang, Tengrui; Guo, Zhengyang; Huo, Xiao; Gong, Yueqing; Li, Chen; Huang, Jiaqi; Wang, Yan; Feng, Hao; Ma, Xiaojuan; Jiang, Changtao; Yin, Qianqian; Xue, Lixiang.
Afiliação
  • Zhang T; Department of Radiation Oncology, Peking University Third Hospital Cancer Center, Peking University Third Hospital, Beijing 100191, China. Electronic address: zhangtengrui@hsc.pku.edu.cn.
  • Guo Z; Center of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing 100191, China. Electronic address: guozhengyang@bjmu.edu.cn.
  • Huo X; Center of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing 100191, China. Electronic address: biohuoxiao@163.com.
  • Gong Y; Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China. Electronic address: bnu_gyq1988@126.com.
  • Li C; Department of Radiation Oncology, Peking University Third Hospital Cancer Center, Peking University Third Hospital, Beijing 100191, China. Electronic address: 1911210521@pku.edu.cn.
  • Huang J; Department of Radiation Oncology, Peking University Third Hospital Cancer Center, Peking University Third Hospital, Beijing 100191, China. Electronic address: huangjq1993@163.com.
  • Wang Y; Center of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing 100191, China. Electronic address: yanwang2019@bjmu.edu.cn.
  • Feng H; Faculty of science, Biology Department, McGill University, Montreal, QC H3A 0C8, Canada. Electronic address: hao.feng@mail.mcgill.ca.
  • Ma X; Center of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing 100191, China. Electronic address: maxiaojuans@163.com.
  • Jiang C; Center of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing 100191, China; Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Key Laboratory of Molecular Cardiovascular
  • Yin Q; Center of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing 100191, China. Electronic address: yinqianqian@bjmu.edu.cn.
  • Xue L; Department of Radiation Oncology, Peking University Third Hospital Cancer Center, Peking University Third Hospital, Beijing 100191, China; Center of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing
EBioMedicine ; 77: 103872, 2022 Mar.
Article em En | MEDLINE | ID: mdl-35158113
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridonas / Benzamidas / Compostos de Bifenilo / Morfolinas / Inibidores Enzimáticos / Metabolismo dos Lipídeos / Proteína Potenciadora do Homólogo 2 de Zeste / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridonas / Benzamidas / Compostos de Bifenilo / Morfolinas / Inibidores Enzimáticos / Metabolismo dos Lipídeos / Proteína Potenciadora do Homólogo 2 de Zeste / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2022 Tipo de documento: Article